{"id":"W3027663151","doi":"10.1016/j.annonc.2020.05.012","title":"Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial","year":2020,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Sunnybrook Hospital","funders":"National Cancer Institute; National Institutes of Health; Puma Biotechnology; American Society of Clinical Oncology","keywords":"Medicine; Neratinib; Tolerability; Oncology; Breast cancer; Internal medicine; Stage (stratigraphy); Metastatic breast cancer; Cancer; Trastuzumab; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001154729,0.0006526312,0.001019432,0.0001554084,0.0001472584,0.0006851801,0.0004773299,0.0005739823,0.003366717],"category_scores_gemma":[0.0009587872,0.0001568438,0.0008936516,0.0001721786,0.0003350865,0.0004985936,0.0001986473,0.001264385,0.000424966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004413619,"about_ca_system_score_gemma":0.0003896249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003653626,"about_ca_topic_score_gemma":0.0008819443,"domain_scores_codex":[0.9996287,0.0001439352,0.00003680315,0.0001017207,0.00003652242,0.00005240264],"domain_scores_gemma":[0.999566,0.00007599989,0.0001340366,0.00005023689,0.00004586605,0.0001277743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8698809,0.01028077,0.004785136,0.001138788,0.002016651,0.0002528217,0.00008508863,0.0008735714,0.01145894,0.0003448865,0.005063871,0.09381871],"study_design_scores_gemma":[0.8637822,0.1069911,0.01998652,0.00005798318,0.001162063,0.0003995021,0.00003435789,0.0009385981,0.00186869,0.0002684431,0.00448168,0.00002881148],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875174,0.00568116,0.0004013529,0.0006185179,0.0002313999,0.0007425128,0.0006926669,0.00008963561,0.004025377],"genre_scores_gemma":[0.9946532,0.001193506,0.000335362,0.0006564704,0.000186252,0.0003400508,0.0008663401,0.00001034427,0.001758454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003366717,"threshold_uncertainty_score":0.01126277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07013071804840221,"score_gpt":0.4039503543111601,"score_spread":0.3338196362627578,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}